Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Reich

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 2, 2015
[Cutaneous granulomatous reactions at botulinum neurotoxin A injection sites: First manifestation of systemic sarcoidosis]V G Herbert, N Blödorn-Schlicht, A Böer-Auer, et al.
The British Journal of Dermatology|March 15, 2012
Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extensionK Reich, J-P Ortonne, A B Gottlieb, et al.
Gut|November 16, 2001
Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's diseaseP Middel, K Reich, F Polzien, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2021
Quality of psoriasis care in Germany - results from the nationwide health care studies PsoHealth 2004-2017A Langenbruch, N Mohr, N Kirsten, et al.
The British Journal of Dermatology|August 14, 2012
An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goalsU Mrowietz, K Kragballe, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 2, 2021
A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS)D Wilsmann-Theis, C Kromer, S Gerdes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 17, 2020
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)A Pinter, M Hoffmann, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 16, 2017
Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3C L Leonardi, A Blauvelt, H L Sofen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 9, 2017
A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features: results from psoriasis patients in SpainL Puig, P C M van de Kerkhof, K Reich, et al.
The British Journal of Dermatology|June 6, 2017
Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trialM Sticherling, U Mrowietz, M Augustin, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 2, 2015
[Cutaneous granulomatous reactions at botulinum neurotoxin A injection sites: First manifestation of systemic sarcoidosis]V G Herbert, N Blödorn-Schlicht, A Böer-Auer, et al.
The British Journal of Dermatology|March 15, 2012
Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extensionK Reich, J-P Ortonne, A B Gottlieb, et al.
Gut|November 16, 2001
Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's diseaseP Middel, K Reich, F Polzien, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2021
Quality of psoriasis care in Germany - results from the nationwide health care studies PsoHealth 2004-2017A Langenbruch, N Mohr, N Kirsten, et al.
The British Journal of Dermatology|August 14, 2012
An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goalsU Mrowietz, K Kragballe, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 2, 2021
A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS)D Wilsmann-Theis, C Kromer, S Gerdes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 17, 2020
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)A Pinter, M Hoffmann, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 16, 2017
Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3C L Leonardi, A Blauvelt, H L Sofen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 9, 2017
A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features: results from psoriasis patients in SpainL Puig, P C M van de Kerkhof, K Reich, et al.
The British Journal of Dermatology|June 6, 2017
Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trialM Sticherling, U Mrowietz, M Augustin, et al.
Pageof 22